Provided by Tiger Trade Technology Pte. Ltd.

SINOPHARM

15.500
-0.430-2.70%
Volume:8.67M
Turnover:134.53M
Market Cap:48.38B
PE:5.80
High:15.840
Open:15.830
Low:15.390
Close:15.930
52wk High:21.258
52wk Low:15.187
Shares:3.12B
HK Float Shares:1.34B
Volume Ratio:1.47
T/O Rate:0.65%
Dividend:0.79
Dividend Rate:5.10%
EPS(LYR):2.672
ROE:8.04%
ROA:2.56%
PB:0.49
PE(LYR):5.80
PS:0.07

Loading ...

Sinopharm Schedules 15 September 2026 EGM to Vote on Full Board Re-election

Bulletin Express
·
Yesterday

Sinopharm Group Announces Extraordinary General Meeting

Reuters
·
Yesterday

Sinopharm Proposes Re-Electing Jin Bin as Chairman for Seventh Board Term

Reuters
·
Yesterday

Sinopharm Group Stock Slides 2.7% in Hong Kong

Dow Jones
·
Yesterday

Sinopharm's Subsidiary Reports 6.06 Billion Yuan Net Profit for First Half, Down 8.97% Year-on-Year

Stock News
·
Aug 28

Sinopharm Accord, Sinopharm Group Unit, Posts H1 Net Profit Attributable to Shareholders Down 8.97% to RMB 606.2 Million

Reuters
·
Aug 28

Analysts Have Been Trimming Their Sinopharm Group Co. Ltd. (HKG:1099) Price Target After Its Latest Report

Simply Wall St.
·
Aug 27

Sinopharm Group Stock Rallies 1.1% in Hong Kong

Dow Jones
·
Aug 26

Sinopharm Group (SEHK:1099) Stock Drifts As Stable Earnings Meet Thin Margins

Simply Wall St.
·
Aug 25

Citigroup Cuts Sinopharm Target Price to HK$20.4 Amid Weak First-Half Results

Stock News
·
Aug 25

Sinopharm Group Stock Falls 1.9% in Hong Kong

Dow Jones
·
Aug 24

Sinopharm Group's Profit Declines 2% in H1

MT Newswires Live
·
Aug 24

Sinopharm Interim Revenue Edges Down on Softness in Pharmaceutical Distribution Business

Reuters
·
Aug 24

Sinopharm Group’s 1H26 Results: Revenue Slips 1.1%, Retail Pharmacy Shines Amid Mixed Segment Performance

Bulletin Express
·
Aug 24

Sinopharm Proposes Re-Election of Lian Wanyong, Yang Binghua as Executive Directors

Reuters
·
Aug 24

Sinopharm Group H1 Revenue RMB 282,799.6 Million

THOMSON REUTERS
·
Aug 24

Sinopharm H1 Net Profit Drops 2.95% to RMB 5.18 Billion; Revenue Slips 1.13% to RMB 282.8 Billion

Reuters
·
Aug 24

Sinopharm to Sell 51% Stake in Guorui Pharmaceutical for 406 Million Yuan

MT Newswires Live
·
Aug 20

Sinopharm Group Sells 42.19% of Guorui Pharmaceutical; SSPC to Assume Control in RMB406.36 Million Connected Deal

Bulletin Express
·
Aug 19

Sinopharm Group and Partners to Divest 51% Stake in Guorui Pharma for RMB 406 Million

Stock News
·
Aug 19